Xueyuan Wang

No. 159 Longpan Road, 210037, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Discovery of an oral, potent and highly selective immunoproteasome inhibitor for the treatment of rheumatoid arthritis and ulcerative colitis.

Discovery of an oral, potent and highly selective immunoproteasome inhibitor for the treatment of rheumatoid arthritis and ulcerative colitis.

Journal: European journal of medicinal chemistry

Published: May 27, 2026

Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors.

Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors.

Journal: European journal of medicinal chemistry

Published: June 20, 2025

Polysaccharides extracted from larvae of Lucilia sericata ameliorated ulcerative colitis by regulating the intestinal barrier and gut microbiota.

Polysaccharides extracted from larvae of Lucilia sericata ameliorated ulcerative colitis by regulating the intestinal barrier and gut microbiota.

Journal: International journal of biological macromolecules

Published: March 19, 2024

Causal association of polyunsaturated fatty acids with biliary tract diseases: A Mendelian randomization study.

Causal association of polyunsaturated fatty acids with biliary tract diseases: A Mendelian randomization study.

Journal: Clinical nutrition ESPEN

Published: October 18, 2023

Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma.

Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma.

Journal: European journal of medicinal chemistry

Published: December 10, 2022

Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.

Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.

Journal: Bioorganic & medicinal chemistry

Published: August 03, 2022

Altered topological properties of brain functional networks in drug-resistant epilepsy patients with vagus nerve stimulators.

Altered topological properties of brain functional networks in drug-resistant epilepsy patients with vagus nerve stimulators.

Journal: Seizure

Published: March 16, 2021

Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma.

Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma.

Journal: Bioorganic & medicinal chemistry

Published: February 06, 2021

Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.

Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: January 20, 2021

In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma.

In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma.

Journal: Aging

Published: June 17, 2020

Epilepsy duration as an independent predictor of response to vagus nerve stimulation.

Epilepsy duration as an independent predictor of response to vagus nerve stimulation.

Journal: Epilepsy research

Published: May 06, 2020

Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors.

Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: June 27, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026